Sonja Nelson

Chief Accounting Officer, ImmunityBio, Inc.

Companies

Motus GI Holdings, Inc.Board member Jun 23, 2021 to Mar 13, 2024¹
Ambrx Biopharma, Inc.Chief financial officer Oct 31, 2023 to Mar 7, 2024²
Ambrx Biopharma Cayman, Inc.Chief financial officer Jul 7, 2023 to Jul 7, 2023³
Ambrx Biopharma Cayman, Inc.Chief Fin. & Operating Officer Jan 3, 2023 to Apr 28, 2023⁴
ImmunityBio, Inc.Chief financial officer Aug 3, 2018 to Jan 13, 2021⁵
ImmunityBio, Inc.Chief Accounting Officer May 20, 2016 to Mar 26, 2018⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Motus GI Holdings, Inc.100,709 shares⁷Jan 5, 2022
Ambrx Biopharma Cayman, Inc.1,000,000 shares⁸Apr 26, 2023
Ambrx Biopharma, Inc.0 shares⁹Mar 7, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 7, 2024Returned to company 22,936 shares of Ambrx Biopharma, Inc.⁹
Dec 11, 2023Granted 50,000 shares of Ambrx Biopharma, Inc.¹⁰
Oct 27, 2023Sold 12,778 shares at $9.82 of Ambrx Biopharma, Inc.¹¹
Apr 26, 2023Granted 1,000,000 shares of Ambrx Biopharma Cayman, Inc.⁸
Jan 5, 2022Granted 82,500 shares of Motus GI Holdings, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMotus GI Holdings, Inc., Board member
2
SEC EDGARAmbrx Biopharma, Inc., Chief financial officer
3
SEC EDGARAmbrx Biopharma Cayman, Inc., Chief financial officer
4
SEC EDGARAmbrx Biopharma Cayman, Inc., Chief Fin. & Operating Officer
5
SEC EDGARImmunityBio, Inc., Chief financial officer
6
SEC EDGARImmunityBio, Inc., Chief Accounting Officer
7
SEC EDGARMotus GI Holdings, Inc. shares after the filing of Jan 5, 2022
8
SEC EDGARAmbrx Biopharma Cayman, Inc. shares after the filing of Apr 26, 2023
9
SEC EDGARAmbrx Biopharma, Inc. shares after the filing of Mar 7, 2024
10
SEC EDGARForm 4 filed Dec 11, 2023
11
SEC EDGARForm 4 filed Oct 31, 2023